Table 2.
Group | BW (g) | FBG (mmol L−1) | FINS (uIU mL−1) |
IRI | ||
---|---|---|---|---|---|---|
Before | After | Before | After | |||
Control | 341.2 ± 7.644◇ | 402.5 ± 8.705a◈ | 6.150 ± 0.5296a◇ | 4.817 ± 0.1833a◇ | 73.89 ± 15.00a | 20.96 ± 0.940a |
T2DM | 316.7 ± 17.09◇ | 232.8 ± 26.64b◈ | 22.07 ± 0.7843b◇ | 27.48 ± 0.9630b◇ | 96.26 ± 40.07b | 188.5 ± 51.80b |
Metformin | 321.2 ± 5.350◇ | 350.0 ± 31.54c◇ | 18.10 ± 0.5125b◇ | 5.000 ± 0.4359a◈ | 188.9 ± 82.10c | 39.72 ± 19.31c |
ICA | 340.7 ± 13.20◇ | 261.6 ± 11.43b◈ | 22.43 ± 0.7796b◇ | 7.650 ± 2.0840a◈ | 118.2 ± 13.62b | 23.24 ± 9.770a |
In each column, values assigned with different superscript lowercases (letters) indicate significant difference (P < 0.05). In each row of BW and FBG, values assigned with different superscript symbols (diamond symbols) also indicate significant difference (P < 0.05). BW body weight; FBG fasting blood glucose; FINS fasting insulin; IRI insulin resistance index